Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Inserm · Istituto Superiore di Sanità · +26 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,022
total citations
- FWCI
- 29.03
- Percentile
- 100%
- References
- 73
Citations per year
Authors
51- ASAntonella SistiguCorresponding
Inserm, Istituto Superiore di Sanità, Institut Gustave Roussy, Université Paris-Saclay
- TYTakahiro Yamazaki
Inserm, Université Paris-Saclay, Institut Gustave Roussy
- EVErika Vacchelli
Institut Gustave Roussy, Université Paris-Saclay
- KCKariman Chaba
Inserm
- DEDavid Enot
Centre de Recherche des Cordeliers, Inserm, La Ligue Contre le Cancer
Topics & keywords
Topics
Keywords
- Cancer research
- Paracrine signalling
- Biology
- Interferon
- Autocrine signalling
- TLR3
- CXCL10
- Immune system
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.